Ekso bionics holdings, inc. (EKSO)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12
Assets
Current assets:
Cash

8,516

10,872

8,058

13,262

9,236

7,655

12,995

13,890

20,572

27,813

33,439

10,701

9,426

16,846

12,800

4,661

12,314

19,552

11,238

16,251

21,133

25,190

7,176

10,965

14,576

805

0

1

29

-

-

-

8

Accounts receivable, net of allowances of $53 and $121, respectively

2,658

5,208

5,206

4,541

3,793

3,660

2,988

3,547

3,574

2,760

2,168

2,107

1,282

1,780

2,200

1,566

2,383

2,069

2,185

2,394

1,455

1,549

1,921

1,493

1,775

549

-

-

-

-

-

-

-

Inventories, net

2,483

2,489

3,342

3,724

3,300

3,371

3,361

2,382

2,833

3,025

2,378

1,896

1,819

1,556

1,915

2,408

2,531

1,056

1,179

1,188

838

622

864

1,277

1,123

725

-

-

-

-

-

-

-

Note receivable, current

-

-

-

-

-

-

-

-

-

-

-

-

-

-

34

40

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Note receivable from stockholder

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

405

238

428

606

506

281

509

584

958

1,339

2,097

597

689

502

533

692

738

436

726

473

447

388

330

401

406

355

-

-

-

-

-

-

-

Deferred cost of revenue, current

-

-

-

-

-

-

-

-

-

-

86

-

46

-

92

0

255

2,088

1,920

1,876

1,677

1,551

1,369

1,169

974

769

-

-

-

-

-

-

-

Total current assets

14,062

18,807

17,034

22,133

16,835

14,967

19,853

20,403

27,937

34,937

40,168

15,301

13,262

20,684

17,574

9,367

18,221

25,201

17,248

22,182

25,550

29,300

11,662

15,306

18,855

3,203

0

-

29

-

-

-

-

Property and equipment, net

1,530

1,657

1,723

1,816

2,331

2,365

2,170

2,271

2,350

2,249

2,301

2,562

2,458

2,435

2,561

2,579

2,617

2,625

2,399

2,154

2,183

2,102

1,957

1,839

1,763

1,575

-

-

-

-

-

-

-

Right-of-use assets

981

1,084

1,174

1,277

1,365

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Note receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

41

50

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred cost of revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

2,502

2,424

2,515

2,245

2,017

1,743

1,397

1,127

804

-

-

-

-

-

-

-

Intangible assets, net

-

-

-

-

-

-

90

225

359

491

626

762

894

1,026

1,162

1,297

1,431

1,584

-

-

-

55

-

-

-

-

-

-

-

-

-

-

-

Goodwill

189

189

189

189

189

189

189

189

189

189

189

189

189

189

189

189

189

189

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Other assets

182

178

172

168

140

134

121

120

124

122

121

118

92

91

94

93

93

97

55

55

55

0

54

54

54

1,002

-

-

-

-

-

-

-

Cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

29

12

-

-

Cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5

-

Total assets

16,944

21,915

20,292

25,583

20,860

17,655

22,423

23,208

30,959

37,988

43,405

18,932

16,895

24,425

21,621

13,575

22,551

32,198

22,126

26,906

30,033

33,474

15,418

18,597

21,801

6,584

0

1

29

29

12

5

8

Liabilities and Stockholders’ Equity
Current liabilities:
Convertible debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

5,062

-

-

-

-

-

-

-

Accounts payable

1,999

1,903

1,362

2,480

2,474

3,156

3,438

2,590

3,392

2,420

990

2,068

2,867

2,374

1,359

2,074

3,618

2,694

2,148

2,306

1,464

783

1,077

1,226

1,044

1,499

-

-

0

-

-

-

-

Accrued liabilities

1,716

1,683

2,589

2,768

3,286

3,489

3,469

3,162

3,011

3,503

2,746

2,458

2,747

3,130

2,982

2,930

2,928

1,885

2,190

1,976

1,657

2,378

1,321

1,264

1,565

1,436

0

0

4

-

-

-

4

Deferred revenues, current

1,231

1,492

1,398

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenues, current

-

-

-

1,369

1,211

1,102

945

1,310

1,292

1,103

1,242

948

975

825

1,098

710

1,222

3,960

3,839

4,032

3,545

3,412

3,454

3,570

2,960

2,419

-

-

-

-

-

-

-

Note payable, current

2,170

2,333

2,333

2,333

2,333

2,333

2,333

2,333

2,333

2,139

1,556

972

389

0

-

-

-

-

-

43

42

-

40

40

39

1,639

-

-

-

-

-

-

-

Lease liabilities, current

434

421

405

393

406

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued restructuring

-

-

-

-

-

-

-

-

-

-

-

95

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other liabilities, current

-

-

-

-

-

-

-

-

-

-

58

46

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Capital lease obligation, current

-

-

-

-

-

-

-

-

-

-

-

-

43

-

67

78

81

80

79

-

-

41

-

-

-

-

-

-

-

-

-

-

-

Liability due to early stock option exercise

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

2

3

-

-

-

-

-

-

-

-

Loan from shareholder

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9

-

9

-

-

-

-

Total current liabilities

7,550

7,832

8,087

9,343

9,710

10,080

10,185

9,395

10,028

9,165

6,592

6,587

7,021

6,329

5,506

5,792

7,849

8,619

8,256

8,357

6,708

6,614

5,896

6,104

5,613

12,055

10

-

14

-

-

-

-

Deferred revenues

1,738

1,789

1,846

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenues

-

-

-

1,761

1,499

1,495

1,535

1,201

766

816

685

653

776

805

822

747

766

4,613

4,399

4,492

4,085

3,895

3,439

2,803

2,447

2,209

-

-

-

-

-

-

-

Note payable

-

-

972

1,535

2,093

2,648

3,199

3,746

4,290

4,830

5,368

5,906

6,445

6,789

-

-

-

0

225

53

65

-

88

99

111

867

-

-

-

-

-

-

-

Lease liabilities

595

711

818

934

1,006

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant liabilities

1,788

4,307

2,131

6,561

1,964

585

1,810

1,128

916

1,648

767

3,810

3,615

3,546

6,165

4,545

6,210

9,195

-

-

-

0

11,819

27,592

88,050

378

-

-

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

-

80

76

73

-

248

238

217

217

-

-

-

768

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contingent success fee liability

-

-

-

-

-

-

-

-

-

-

13

37

117

116

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contingent consideration liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

768

768

768

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Other non-current liabilities

45

479

17

45

54

119

27

36

47

138

65

73

87

92

132

162

205

195

-

-

-

165

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

69

78

-

96

105

114

124

-

-

-

-

-

-

-

Due to Related Parties, Noncurrent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9

-

-

-

-

3

Accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

Loan from shareholder

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

17

17

-

-

Accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Loan from shareholder

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9

-

Total liabilities

11,716

15,118

13,871

20,179

16,326

14,927

16,836

15,582

16,120

16,597

13,738

17,304

18,278

17,894

13,393

12,014

15,798

23,390

12,880

12,971

10,936

10,674

21,340

36,706

96,337

15,633

-

10

-

18

18

9

8

Commitments and contingencies (Note 14)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

-

-

-

-

-

Convertible preferred stock issuable in series, $0.001 par value; 10,000,000 and 33,523,600 shares authorized at December 31, 2014 and December 31, 2013, respectively; none and 25,923,872 shares issued and outstanding at December 31, 2014 and December 31, 2013, respectively; liquidation preference of $1.07 per share at December 31, 2013

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

27,324

-

-

-

-

-

-

-

Convertible preferred stock issuable in series, $0.001 par value; 10,000,000 and 22,000,000 shares authorized at March 31, 2014 (unaudited) and December 31, 2013 respectively; none and 25,923,873 and shares issued and outstanding at March 31, 2014 (unaudited) and December 31, 2013 respectively; liquidation preference of $2.85 - $4.11 per share at December 31, 2013

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Stockholders’ equity:
Convertible preferred stock, $0.001 par value; 10,000 shares authorized; none issued and outstanding at March 31, 2020 and December 31, 2019

0

0

0

0

0

0

0

0

0

0

0

0

-

0

0

0

0

0

0

0

0

0

-

-

-

-

-

-

0

-

-

-

-

Common stock, $0.001 par value; 141,429 shares authorized; 5,843 and 5,795 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

6

6

75

75

68

63

63

61

60

60

60

26

22

22

21

16

109

15

102

102

102

102

78

78

78

21

6

6

6

5

5

5,000

5

Additional paid-in capital

190,811

190,019

186,629

186,142

182,107

173,903

172,721

167,823

167,381

165,825

165,060

130,598

121,880

121,291

117,498

102,341

101,686

100,185

95,890

95,394

94,911

94,499

45,645

45,482

45,182

1,638

25

-

25

18

0

0

-

Accumulated other comprehensive income

223

50

274

-50

56

-92

-183

-227

-547

-340

-277

-155

49

79

-7

10

-

-1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Additional Paid in Capital, Preferred Stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

25

-

-

-

-

0

Accumulated deficit

-185,812

-183,278

-180,557

-180,763

-177,697

-171,146

-167,014

-160,031

-152,055

-144,154

-135,176

-128,841

-123,334

-114,861

-109,284

-100,806

-95,042

-91,391

-86,746

-81,561

-75,916

-71,801

-51,645

-63,669

-119,796

-38,032

-

-40

-

-

-

-

-4

Deficit accumulated during the development stage

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

41

-

16

-12

-10

-9

-

Total stockholders’ equity

5,228

6,797

6,421

5,404

4,534

2,728

5,587

7,626

14,839

21,391

29,667

1,628

-1,383

6,531

8,228

1,561

6,753

8,808

9,246

13,935

19,097

22,800

-5,921

-18,108

-74,535

-8,765

-9

-

15

11

-

-4

-

Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-8

-

-

-

-

0

Common Stock, Shares Authorized

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

75,000

-

-

-

-

75,000

Common Stock, Shares Issued

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,350

-

-

-

-

5,000

Common Stock, Shares Outstanding

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,350

-

-

-

-

6,350

Total liabilities and stockholders’ equity

16,944

21,915

20,292

25,583

20,860

17,655

22,423

23,208

30,959

37,988

43,405

18,932

16,895

24,425

21,621

13,575

22,551

32,198

22,126

26,906

30,033

33,474

15,418

18,597

21,801

6,584

0

1

29

29

-

5

8

Total Stockholders Equity (Deficit)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5

-

-

Total Liabilities and Stockholders Equity (Deficit)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5

-

-